Nanjing RainGene Biotechnology Co., Ltd. is an innovative R & D company, based on the PKU-Nanjing Institute of Translational Medicine, Nanjing, China. It is a high-tech enterprise company who are committed to developing CRISPR-based molecular diagnostic products. The company has gathered leadership by Professor Jing-Wei Xiong and Dr. Jun Tian, and has established a highly competitive molecular diagnosis team of more than 20 talent people, including 4 Ph.D. and 8 MS scientists/engineers.

Nanjing RainGene Biotechnology Co., Ltd. is located in Jiangbei District, Nanjing, which is mainly responsible for the development of molecular diagnostic kits, and the Nanjing RainGene Biotechnology Co., Ltd., which is located in Xiaoshan District, Hangzhou, is mainly responsible for the development of diagnostic devices. Combined with the advanced concept of molecular diagnostic “sample-in and results out”, we aim to create our POCT products to detect infectious diseases quickly and accurately. The products cover the detection of infectious pathogens from the respiratory tract and intestines, and will expand pathogen products to the animal husbandry and pets market. The company strives to become a leading enterprise in the molecular diagnostic industry within five years.